Mark W. Ball

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Diana Miao, Claire A. Margolis, Wenhua Gao et al. · Science · 2018 · 1.3K citations · Full text

Medicine, Molecular Genetics, Oncology +17

Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry

Phillip M. Pierorazio, Michael H. Johnson, Mark W. Ball et al. · European Urology · 2015 · 398 citations

Medicine, Internal Medicine, Nephrology +14

AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin

Allicia C. Girvan, Yun Teng, Lavona Casson et al. · Molecular Cancer Therapeutics · 2006 · 234 citations · Full text

Medicine, Molecular Biology, Oncology +13

Trifecta and optimal perioperative outcomes of robotic and laparoscopic partial nephrectomy in surgical treatment of small renal masses: a multi‐institutional study

Homayoun Zargar, Mohamad E. Allaf, Sam B. Bhayani et al. · British Journal of Urology · 2014 · 210 citations

Medicine, Perioperative Medicine, Surgery +17

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17